Home › Compare › SCAL vs ADC

SCAL vs ADC: Dividend Comparison 2026

SCAL yields 1000000.00% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCAL wins by $4.7683925249533696e+36M in total portfolio value
10 years
SCAL
SCAL
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full SCAL calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — SCAL vs ADC

📍 SCAL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCALADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCAL + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SCAL pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCAL
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, SCAL beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCAL + ADC for your $10,000?

SCAL: 50%ADC: 50%
100% ADC50/50100% SCAL
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

SCAL
No analyst data
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCAL buys
0
ADC buys
0
No recent congressional trades found for SCAL or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCALADC
Forward yield1000000.00% ✓4.13%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$4.7683925249533696e+36M$178.9K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$80,797.29
Total dividends collected$4.7683311610149396e+36M$156.7K ✓
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: SCAL vs ADC ($10,000, DRIP)

YearSCAL PortfolioSCAL Income/yrADC PortfolioADC Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,990$580.36+$100.00M → SCAL
2$934,786,450,701$934,679,439,252.34$12,301$860.26+$934786.44M → SCAL
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,104$1,298.62+$8165787108.56M → SCAL
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$16,691$2,008.16+$66665884190957.63M → SCAL
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$20,580$3,205.09+$508662171058048128.00M → SCAL
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$26,754$5,330.02+$3.62723524842849e+21M → SCAL
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$37,196$9,345.14+$2.417368115915061e+25M → SCAL
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$56,244$17,523.09+$1.5056740286145463e+29M → SCAL
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$94,286$35,736.21+$8.764771002818475e+32M → SCAL
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$178,949$80,797.29+$4.7683925249533696e+36M → SCAL

SCAL vs ADC: Complete Analysis 2026

SCAL — Stock

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.

Full SCAL Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this SCAL vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCAL vs SCHDSCAL vs JEPISCAL vs OSCAL vs KOSCAL vs MAINSCAL vs NNNSCAL vs EPRTSCAL vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.